Beam Therapeutics Inc. - Common Stock — Dividend History & Yield (NASDAQ:BEAM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

News

Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse

Beam Therapeutics To Present Initial Data From Ongoing Phase 1/2 Clinical Trial Evaluating BEAM-301 For Treatment Of Glycogen Storage Disease Type Ia At 33rd Annual Congress Of ESGCT

Reflection debuts Beam, an open-weight AI model to rival Chinese models at lower compute cost

Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity

Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)

As Claude Enters the Gene-Editing Arena, There’s Still a Long-Term Case for BEAM Stock

Prime Medicine: A Buy Due To BLA Filing H1 '27 And In Vivo Therapy Development (PRME)

Squeeze Watch: 10 Stocks With Over 33% Short Interest

Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP)

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Can Intellia's Pipeline Progress Create Long-Term Value Amid Rivalry?

Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout